| Market Cap | 3.8B 570M 511M 473M 428M 800M 54.27B 809M 5.65B 2.25B 28.4B 2.14B 2.09B 90.16B | P/E 2024 |
65.6x | P/E 2025 | 89.6x |
|---|---|---|---|---|---|
| Enterprise Value | 3.32B 498M 447M 413M 374M 699M 47.43B 707M 4.94B 1.97B 24.82B 1.87B 1.83B 78.79B | EV / Sales 2024 |
3.66x | EV / Sales 2025 | 4.3x |
| Free-Float |
33.12% | Yield 2024 |
0.16% | Yield 2025 | 0.23% |
| 1 day | -1.06% | ||
| 1 week | -6.77% | ||
| Current month | -9.93% | ||
| 1 month | -8.60% | ||
| 3 months | -3.63% | ||
| 6 months | -9.05% | ||
| Current year | -13.89% |
| 1 week | 7.37 | 7.91 | |
| 1 month | 7.37 | 8.48 | |
| Current year | 6.63 | 11.02 | |
| 1 year | 6.63 | 11.02 | |
| 3 years | 5.84 | 11.85 | |
| 5 years | 5.84 | 15.17 | |
| 10 years | 5.84 | 15.17 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ai Guo Shi
CEO | Chief Executive Officer | 62 | 06/04/2022 |
Jin feng Yue
DFI | Director of Finance/CFO | - | 02/12/2022 |
Li Jun Wu
PRN | Corporate Officer/Principal | 52 | 01/02/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Wen Bo Su
CHM | Chairman | 60 | 08/05/2014 |
Ai Guo Shi
CHM | Chairman | 62 | 30/06/2017 |
Zhi Jun Liu
BRD | Director/Board Member | 54 | 12/04/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.06% | -6.77% | -17.52% | -28.67% | 576M | ||
| +0.50% | +1.38% | +57.09% | +129.96% | 1,143B | ||
| +0.86% | +5.14% | +45.00% | +86.15% | 647B | ||
| -0.14% | +0.42% | +25.69% | +105.85% | 506B | ||
| -0.05% | +2.28% | +49.14% | +67.74% | 384B | ||
| -0.63% | -5.97% | +61.93% | +37.06% | 350B | ||
| +0.34% | +2.15% | +25.26% | +54.27% | 293B | ||
| -0.45% | +1.16% | +1.74% | +26.08% | 265B | ||
| +0.87% | +3.08% | +54.69% | +72.74% | 242B | ||
| +0.08% | +3.67% | +35.05% | +107.78% | 197B | ||
| Average | +0.03% | +0.41% | +33.81% | +65.90% | 402.81B | |
| Weighted average by Cap. | +0.25% | +0.71% | +43.67% | +89.00% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 980M 147M 132M 122M 110M 206M 14B 209M 1.46B 581M 7.33B 552M 540M 23.26B | 916M 137M 123M 114M 103M 193M 13.08B 195M 1.36B 542M 6.84B 515M 504M 21.73B |
| Net income | 60.07M 9.01M 8.08M 7.47M 6.77M 12.65M 858M 12.8M 89.36M 35.59M 449M 33.81M 33.1M 1.43B | 49.21M 7.38M 6.62M 6.12M 5.54M 10.36M 703M 10.48M 73.2M 29.16M 368M 27.7M 27.11M 1.17B |
| Net Debt | -357M -53.56M -48.05M -44.43M -40.24M -75.17M -5.1B -76.08M -531M -212M -2.67B -201M -197M -8.47B | -479M -71.84M -64.46M -59.59M -53.97M -101M -6.84B -102M -713M -284M -3.58B -270M -264M -11.37B |
Employees
1,332
Sector
Pharmaceuticals
Calendar
06:00pm
Earnings release - Q3 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/10/26 | CNY 7.440 | -1.06% | 4,309,800 |
| 27/10/26 | CNY 7.520 | -2.34% | 3,857,900 |
| 26/10/26 | CNY 7.700 | -0.26% | 3,244,900 |
| 23/10/26 | CNY 7.720 | +0.13% | 4,436,999 |
| 22/10/26 | CNY 7.710 | -2.41% | 2,692,405 |
















